Evidence map›Paper›PMID 36104796›Full record

ArticleClinical hypertension2022

Immediate pressor response to oral salt and its assessment in the clinic: a time series clinical trial.

Sepiso K Masenga, Leta Pilic, Benson M Hamooya, Selestine Nzala, Douglas C Heimburger, Wilbroad Mutale, John R Koethe, Annet Kirabo, Sody M Munsaka, Fernando Elijovich

Open access · diamondAbstract read
In one paragraph

Article in Clinical hypertension, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Salt Taste and Salt Sensitive Hypertension in HIV.Current hypertension reports · 2023
    Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 3 countries.

Sepiso K MasengaHAND Research Group, School of Medicine and Health Sciences, Mulungushi University, Akapelwa street, LUTH Premises, Livingstone, Zambia. smasenga@mu.ac.zm.ORCID http://orcid.org/0000-0003-4376-5831
Leta PilicFaculty of Sport, Health and Applied Science, St. Mary's University, Twickenham, London, UK.ORCID https://orcid.org/0000-0001-8046-1269
Benson M HamooyaHAND Research Group, School of Medicine and Health Sciences, Mulungushi University, Akapelwa street, LUTH Premises, Livingstone, Zambia.ORCID https://orcid.org/0000-0003-1385-0998
Selestine NzalaSchool of Public Health and School of Medicine, University of Zambia, Lusaka, Zambia.ORCID https://orcid.org/0000-0002-2065-3987
Douglas C HeimburgerSchool of Public Health and School of Medicine, University of Zambia, Lusaka, Zambia.ORCID https://orcid.org/0000-0003-3551-9710
Wilbroad MutaleSchool of Public Health and School of Medicine, University of Zambia, Lusaka, Zambia.ORCID https://orcid.org/0000-0002-4891-6750
John R KoetheDepartment of Medicine, Vanderbilt Institute for Global Health and Vanderbilt University Medical Center, Nashville, TN, USA.ORCID https://orcid.org/0000-0001-6490-6942
Annet KiraboDepartment of Medicine, Vanderbilt Institute for Global Health and Vanderbilt University Medical Center, Nashville, TN, USA.ORCID https://orcid.org/0000-0001-8580-9359
Sody M MunsakaDepartment of Biomedical Sciences, School of Health Sciences, University of Zambia, Lusaka, Zambia.ORCID https://orcid.org/0000-0002-6917-3888
Fernando ElijovichDepartment of Medicine, Vanderbilt Institute for Global Health and Vanderbilt University Medical Center, Nashville, TN, USA.ORCID https://orcid.org/0000-0002-2511-056X
Mulungushi University · ZMSt Mary's University Twickenham London · GB

Funding

Vanderbilt-Emory-Cornell-Duke Global Health Fellowship Consortium-Expanding Diversity for Global Equity (EDGE)D43TW009337 · FIC · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ALIYU, MUKTAR HASSAN, HEIMBURGER, DOUGLAS CORBETT · 2017 to 2021
$6.3M
UNZA-Vanderbilt Training Partnership for HIV-NCD Research (UVP-2)D43TW009744 · FIC · VANDERBILT UNIVERSITY MEDICAL CENTER · PI HEIMBURGER, DOUGLAS CORBETT, MUTALE, WILBROAD · 2015 to 2025
$3.2M
Immune Mechanisms of Salt-Sensitive hypertensionR01HL144941 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI KIRABO, ANNET · 2021 to 2025
$3.0M
Role of Salt, Isoketal-modified Proteins and Dendritic Cells in HypertensionK01HL130497 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI KIRABO, ANNET · 2016 to 2020
$803k
Deep phenotypic and functional characterization of salt-responsive immune cells in human salt senstive hypertension using CTE-seqR03HL155041 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI KIRABO, ANNET · 2021 to 2022
$173k
FIC NIH HHS D43 TW009337FIC NIH HHS D43 TW009744NHLBI NIH HHS K01 HL130497NHLBI NIH HHS R01 HL144941NHLBI NIH HHS R03 HL155041NIH HHS K01HL130497, R03HL155041, and R01HL144941
6 · The paper itself

Abstract

backgroundHigh blood pressure (BP) is associated with high-salt consumption especially in sub-Saharan Africa. Although the pressor effect of salt is viewed as a chronic effect, some studies suggest that a salty meal may increase BP immediately in some individuals, and that this effect may cause endothelial dysfunction. Therefore, the aim of our research was to study the immediate pressor response to oral salt (IPROS) and its determinants, with the expectation that a simple methodology may be devised to diagnose it in the clinic or in low-resource environments.

methodsWe conducted a time series trial at Livingstone Central Hospital. We present data in 127 normotensive participants who ingested 2 g of sodium chloride; their BP was monitored for 120 minutes in intervals of 10 minutes. Sociodemographic and clinical data were collected. Descriptive and inferential statistics were used for analyses of data.

resultsMedian age was 30 years (interquartile range, 22-46 years) and 52% were female patients. An increase of ≥10 mmHg in mean arterial pressure (MAP), considered a clinically significant IPROS, was present in 62% of participants. Systolic BP 30 minutes after the salt load was a significant predictor of IPROS, avoiding the need to calculate MAP in the clinic setting.

conclusionsWe confirm the presence of an IPROS in a high proportion (62%) of otherwise normotensive participants. The average time course for this response was 30 minutes and its duration was sustained for the 120-minutes period of study in most of the participants. Prediction of IPROS by ∆SBP (change in systolic blood pressure) at 30 minutes allows for easy assessment of possible responder status in the clinic. Our data indicate that the IPROS to oral salt-loads in the range currently consumed by the Western world and African populations in single meals may increase the 24-hour BP load, which is a risk factor for hypertension and target organ damage. The relevance of our findings indicates the need to include dietary sodium assessment in the diagnosis, prevention, and management of high BP.

Indexed as

Arterial pressureBlood pressureHypertensionImmediate pressor responsePulse pressureSodium chlorideSystolic pressure

Identifiers

PMID36104796
PMCPMC9476589
OpenAlexW4295766030

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.